These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31399987)

  • 1. Urinary Biomarkers of Renal Fibrosis.
    Zhou LT; Lv LL; Liu BC
    Adv Exp Med Biol; 2019; 1165():607-623. PubMed ID: 31399987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.
    Zhou D; Tian Y; Sun L; Zhou L; Xiao L; Tan RJ; Tian J; Fu H; Hou FF; Liu Y
    J Am Soc Nephrol; 2017 Feb; 28(2):598-611. PubMed ID: 27624489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary biomarkers of kidney dysfunction].
    Piéroni L; Cristol JP
    Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis.
    Cao YH; Lv LL; Zhang X; Hu H; Ding LH; Yin D; Zhang YZ; Ni HF; Chen PS; Liu BC
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F514-22. PubMed ID: 25904701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Peptidomic Biomarkers in Kidney Diseases.
    Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feature selection and classification of urinary mRNA microarray data by iterative random forest to diagnose renal fibrosis: a two-stage study.
    Zhou LT; Cao YH; Lv LL; Ma KL; Chen PS; Ni HF; Lei XD; Liu BC
    Sci Rep; 2017 Jan; 7():39832. PubMed ID: 28045061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
    Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
    Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
    Tesch GH
    Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aside from acute renal failure cases, are urinary markers of glomerular and tubular function useful in clinical practice?
    Bastard JP; Fellahi S; Regeniter A; Capeau J; Ronco P; Plaisier E
    Clin Biochem; 2019 Mar; 65():1-6. PubMed ID: 30685208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of urinary proteomics in renal disease research using animal models.
    Lv Y; Cai G; Chen X
    Adv Exp Med Biol; 2015; 845():145-50. PubMed ID: 25355577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.
    Zakeri R; Burnett JC; Sangaralingham SJ
    Clin Chim Acta; 2015 Mar; 443():108-13. PubMed ID: 25512164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary biomarkers for acute kidney injury in dogs.
    De Loor J; Daminet S; Smets P; Maddens B; Meyer E
    J Vet Intern Med; 2013; 27(5):998-1010. PubMed ID: 23952327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kidney injury molecule-1 in renal disease.
    Moresco RN; Bochi GV; Stein CS; De Carvalho JAM; Cembranel BM; Bollick YS
    Clin Chim Acta; 2018 Dec; 487():15-21. PubMed ID: 30201372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults.
    Stiegel MA; Pleil JD; Sobus JR; Angrish MM; Morgan MK
    Biomarkers; 2015; 20(6-7):436-52. PubMed ID: 26616147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology.
    Schaub S; Mayr M; Hönger G; Bestland J; Steiger J; Regeniter A; Mihatsch MJ; Wilkins JA; Rush D; Nickerson P
    Transplantation; 2007 Jul; 84(1):104-12. PubMed ID: 17627245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
    Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
    J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic urinary biomarker approach in renal disease: from discovery to implementation.
    Schanstra JP; Mischak H
    Pediatr Nephrol; 2015 May; 30(5):713-25. PubMed ID: 24633400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.
    Tanaka T; Noiri E; Yamamoto T; Sugaya T; Negishi K; Maeda R; Nakamura K; Portilla D; Goto M; Fujita T
    Nephron Exp Nephrol; 2008; 108(1):e19-26. PubMed ID: 18182783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.
    Lee H; Fujimoto M; Ohkawara T; Honda H; Serada S; Terada Y; Naka T
    Biochem Biophys Res Commun; 2018 Apr; 498(4):1045-1051. PubMed ID: 29550485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of genetics and epigenetics to progression of kidney fibrosis.
    Tampe B; Zeisberg M
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.